Bioxytran Inc (BIXT)

[profitdaddy]

Great article! I have been following this company for a while now and I'm glad to see filings up to date and some trading ramping up. I think this one will move easily over $1.00 once the public starts getting a look into this huge potential.

[misiu143]

Yes ,it is a very good and informative article..

Thank you.

[Vision and Value]

Has anyone here seen this article? Huge for BIXT. I'm a fan of David Platt. Pretty confident the COVID data will knock it out of the park, not to mention BXT-25 is just an amazing ingenious drug

https://microcapdaily.com/navigating-through-the-galectin-therapeutics-nasdaq-galt-triangle-in-search-of-therapies/

[Retire43]

Card deck shows a device to test the oxygen saturation of tissue!

[Retire43]

Website shows a second Covid drug in IV form!

[Ecomike]

BIXT has done what the peasant pundits claimed was impossible.

Folks should check out the $BIXT website and 100% professional slide decks on it for the whole story...

This could be a 20 bagger + stock in 2 years... if they get FDA final approval.

[Ecomike]

The CEO's credentials are to die for. Multiple Biotechs up the Billion dollar levels... A history of Success and Phase III Covid19 EUA trial approved.. For a non toxic compound, that early tests showed eliminated any detectable amount of Covid19 in 3 days from the blood and organs? Wow...

[Retire43]

Something like 2 years and 2 months!
BIXT making a comeback to trading!

2 new patents
Trade mark for its Drug!

[Ecomike]

Indeed it has....New day has dawned and arrived here at BIXT

Last call for sub Dollar shares here IMO

[Ecomike]

BIXT is on fire now. Folks should check out the slide shows, the Investors deck, the Science etc slide shows, 100% top line professional operation here Covid19 Phase III EUA trial approved to start...

[Retire43]

I think BIXT should be congratulated for getting off the CE status!
I know it had to have been a monumental effort to achieve this!

Not very many companies come back to trading after having been caveat emptor status!

[Retire43]

??
Yes. TDAmeritrade accepting orders

Schwab have to call in but they will wave the live broker fee

Fidelity started today!

[Retire43]

Yes. I just saw the patent info and trademark info on the 8K.
ProLectin!

[AXNMAN]

$BIXT... Chart tells me. Time to buy. $0.70 is the first target.
Fundamentals Are tremendous. Caveat emptor Signal has been removed. New patent filing. Good story here. Do some homework.

[AXNMAN]

$BIXT... Chart tells me. Time to buy. $0.70 is the first target.
Fundamentals Are tremendous. Caveat emptor Signal has been removed. New patent filing. Good story here. Do some homework.

[Big Brother]

CE was removed today.

[Bodhi_Trades]

BIXT Pink Current. Nice SS - I expect company will start updating.
https://www.otcmarkets.com/stock/BIXT/profile

[Ecomike]

The SEC really screwed the Pooch on this one, and people died of Covid because of it IMO.

Huge news is out. $BIXT Patents on Steroids.

There is no excuse for OTC foot dragging on this. IMO. No excuse at all.

Biggest lie ever told: "We are with the Government, and we are here to help"

https://ih.advfn.com/stock-market/USOTC/bioxytran-pk-BIXT/stock-news/88339101/current-report-filing-8-k

10.69 Approval of International Patent WO2022/099052 - Polysaccharides for Use in Treating Sars-Cov-2 Infections, dated May 12, 2022.

10.70 Approval of International Patent WO2022/099061 - Polysaccharides for IV Administration that Treat SARS-CoV-2 Infections, dated May 12, 2022.

10.71 Official USPTO Notice of Publication under 12(A) for the Trademark ProLectin

Item 8.01 Other Events.

On May 12th, 2022, the International Bureau of the Patent Cooperation Treaty (PCT) approved and published two patent applications from Bioxytran, Inc.:

? WO 2022/099061 - Polysaccharides for Use in Treating Sars-Cov-2 Infections - The invention provides a method for treating SARS-CoV-2 by administering an effective amount of galactomannans to a subject in need thereof.

? WO2022/099061 - Polysaccharides for IV Administration that Treat Sars-Cov-2 Infections - The invention provides a method for treating SARS-CoV-2 by administering an effective amount of pectin polysaccharides to a subject in need thereof.

On June 8, 2022 United States Patent and Trademark Office (USPTO) approved the Trademark ProLectin to be published in the published in the Trademark Official Gazette (TMOG) on June 28, 2022.

[Retire43]

Still can’t trade!
TDAmeritrade
Schwab
Fidelity

[Ecomike]

The $BIXT 10-Q filing is here

https://www.otcmarkets.com/filing/html?id=15839442&guid=f4awkpVp4tRSJth

[Ecomike]

Great DD that needs a re-fresh $BIXT, and even the CDC has admitted Covid19 and its descendants are here to stay, and that better solutions are needed.

Long haul Covid is now a huge problem and even the medical industry has admitted this in recent weeks.

"Just Letting everyone know that you can only place orders at Charles Schwab! After TD Ameritrade stopped allowing opening orders in May this year there was very little volume traded down to the trips. This stock is super thin. When it was trading I would estimate there was about 1.25 mill shares in the real float. They got rid of all their toxic debt over the past year and now holding 1.0 million of fixed debt. This share structure is very unique. This is a PHASE 3 company in COVID-19. Go to their website www.bioxytraninc.com and click on their pipeline. They look to me in the starting phase 3 part. I also verified this on clinical trials.gov. You type in Prolectin-M and it looks like the protocol is there they just need to start recruiting. Looks like they have a chewable tablet that binds to the spike protein and prevents it from entering the cells. There are no safety issues with this drug so if they get efficacy this can compete with Pfizers Paxlovid. This should be easily worth hundreds of millions. They just gotta get the caveat emptor removed. Their website morphed a ton over the past couple of months. Ive been watching intently. Any newbies here just know they never missed a filing. So the troll that said their going to be delisted think again. No reason to take out toxic debt - put a complete platform technology that treats early covid unless they were going to do something big. The shares down here are stupid cheap. Sitting on the bid doesnt seem to work there are no sellers. There was a very active investor base at one time that believes in this team. I did some research on Platt and he’s like the king of galectins. He knows what he’s doing. This company has great potential. Its probably on its way to active trading soon. I would guess they filed their 15c211 with FINRA. So its a waiting game. I've been seeing website tweaks every so often. So dont be fooled by the troll here. Something big is going down. Cant wait to see what unfolds."

[Ecomike]

Looks like all we are waiting on now is OTC Markets to answer the phone and do their job to remove the CE, or the 90 day wait for the SEC to complete their review of the S-1 filing earlier this year. I hear if the SEC has not taken action after 90 days, the S-1 is cleared automatically.

No one registers a scam with an S-1 SEC registration for an already FDA approved Phase III trial for Covid19 EUA use, if it was ever a scam..

This is one to keep a watchful eye on folks. $BIXT

Thanks for the heads up that 10-Q is already filed as well.

This could be a game changer...

[Ecomike]

Sweet, thanks for the link. $BIXT

[Ecomike]

CE is only a problem for US Buyers at the wrong brokers.

And BIXT is not the only one with a CE that OTC is dragging their feet on, that has a huge market cap and solid share prices. Another one I am in is at $1.35/share with a bare ask of only 100 shares on the way to $7.00/share ask.

[Ecomike]

Well that prediction went up in flames. $BIXT filed an SEC S-1

Surprize surprize surprize

[Retire43]

Quarterly report filed

[Retire43]

[Retire43]

Emerging Growth Conference 30
Today - 9:30 AM Eastern
Register for the Conference Here

Conference Agenda:?
9:30 - 10:00
Ur-Energy (NYSE American: URG) (TSX: URE)
John W. Cash, CEO

10:00 - 10:45
Todos Medical Ltd. (OTCQB: TOMDF)
Gerald Commissiong, CEO

10:45 - 11:30
Bioxytran (OTC: BIXT)
Mike Sheikh, Executive Vice President

11:30 - 12:00
Can B Corp. (OTCQB: CANB)
Marco Alfonsi, CEO

12:00 - 12:30
VirExit Technologies, Inc. (OTC Pink: VXIT)
James Katzaroff, CEO

12:30 - 1:00
Silver Bullet Mines (OTC Pink: SBMCF)
Peter Clausi, CEO

1:00 - 1:30
Pervasip Corp., (OTC Pink: PVSP)
German Burtscher, President / CEO

1:30 - 2:00
Gold79 Mines Ltd. (OTCQB: AUSVF)
Derek Macpherson, President / CEO

2:00 - 2:30
Globestar Therapeutics Corp. (OTCQB: GSTC)
James Katzaroff, CEO

2:30 - 3:00
American Premium Water Corporation (OTC Pink: HIPH)
Ryan Fishoff, CEO

All interested in attending should visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

Register for the Conference Here

[Retire43]

Tomorrow conference call:

Excited to represent $BIXT & present #Galectin Science @EmergingGrowthC. Learn about the #Glycovirology platform, #COIVD19 case study, & how it’s different from other #GalectinInhibitors & oral #AntiVirals. #glycotime #glyco25 $GLTO $GALT $VERU $PFE $MRK https://t.co/FfFRz4ev1d

— Mike Sheikh (@MikeSheikh2) April 26, 2022

[samsamsamiam]

Interesting.
Doesn’t Mike Sheikh who is partnered with Dana Salzarulo own shares and warrants here?

https://www.sec.gov/cgi-bin/srch-edgar?text=Sheikh%2C+Michael&first=2022&last=2022

[Retire43]

https://www.thelifesciencesreport.com/article/2022/04/04/can-we-make-a-pill-to-end-the-pandemic.html

[Retire43]

https://finance.yahoo.com/news/galecto-publishes-results-showing-safety-120000995.html

[Retire43]

Galecto confirmed BIXT study.!

[ErnieBilco]

Where are you seeing warrants? I don't see any listed

[Longer Than Most]

BIXT warrants at $2? Am I reading that correctly?

[ErnieBilco]

Some hedge fund needed to get out? I don't know but it gave me an exit

[HAGLLC]

Anyone know why BIXT opened up and was closes again.

[TradeForProfits]

$BIXT chart tells me $1 will be just a blip on way to much higher values, could an up-list be coming this year?

[TradeForProfits]

putting the $BIXT pieces together... reading the filings and website puts many pieces of the puzzle together. CE in this case doesn't mean much at all and that's partly why i think Schwab allows trading in it. Toxic debt was handled while still CE should be all the sign anyone needs. You don't invest that kind of money into a dead drug, something is brewing big here imo. Check out the latest on their website: https://www.bioxytraninc.com/

https://www.bioxytraninc.com/resources#SCIENTIFIC-PUBLICATIONS <-- wow

excellent read here: https://www.walshmedicalmedia.com/abstract/galectin-antagonist-use-in-mild-cases-of-sarscov2-pilot-feasibility-randomised-open-label-controlled-trial-61087.html

Results: This pilot trial demonstrated the feasibility to recruit and randomize participants. By day 7, following treatment with Prolectin-M, Ct value of Rd/Rp+N gene increased by16.41 points, 95% (CI 0.3527 to 32.48, p=0.047). Similarly, small envelope (E) gene also increased by 17.75 points (95% CI,-0.1321 to 35.63, p=0.05). The expression of N1, N2 genes went below detectable thresholds by day 3 (Mann Whitney U=0.000, p<0.029).

Undetectable levels in 3 DAYS !!!

[TradeForProfits]

i see this going way higher than that

[PStockPickz]

Why is this up so high with a CE? Pretty impressive

[Longer Than Most]

To $1!!!

[$theDDmessiah]

With fidelity?

[68metal]

I bought 5,000 shares @.29?

[$theDDmessiah]

Just tried no it's not

[68metal]

Seems caveat emptor is no longer an issue, on fidelity it is now trade able.

[Retire43]

RSI Is OVER 91!

[BugStocks_com]

Just Letting everyone know that you can only place orders at Charles Schwab! After TD Ameritrade stopped allowing opening orders in May this year there was very little volume traded down to the trips. This stock is super thin. When it was trading I would estimate there was about 1.25 mill shares in the real float. They got rid of all their toxic debt over the past year and now holding 1.0 million of fixed debt. This share structure is very unique. This is a PHASE 3 company in COVID-19. Go to their website www.bioxytraninc.com and click on their pipeline. They look to me in the starting phase 3 part. I also verified this on clinical trials.gov. You type in Prolectin-M and it looks like the protocol is there they just need to start recruiting. Looks like they have a chewable tablet that binds to the spike protein and prevents it from entering the cells. There are no safety issues with this drug so if they get efficacy this can compete with Pfizers Paxlovid. This should be easily worth hundreds of millions. They just gotta get the caveat emptor removed. Their website morphed a ton over the past couple of months. Ive been watching intently. Any newbies here just know they never missed a filing. So the troll that said their going to be delisted think again. No reason to take out toxic debt - put a complete platform technology that treats early covid unless they were going to do something big. The shares down here are stupid cheap. Sitting on the bid doesnt seem to work there are no sellers. There was a very active investor base at one time that believes in this team. I did some research on Platt and he’s like the king of galectins. He knows what he’s doing. This company has great potential. Its probably on its way to active trading soon. I would guess they filed their 15c211 with FINRA. So its a waiting game. I've been seeing website tweaks every so often. So dont be fooled by the troll here. Something big is going down. Cant wait to see what unfolds.

[hondaboost]

BIXT, This Scam will be Revoked and Cancelled by the yearend. LOL!

[hondaboost]

It was $0.0011. 2021-09-29, $0.0011, Volumes: 200,000. LOL!